CoChat

Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas

Open access
Wahrenbrock, Mark, Borsig, Lubor, Le, Dzung, Varki, Nissi, Varki, Ajit · 2003 · Journal of Clinical Investigation

The DOI matches its Crossref record; 87 of the 88 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Trousseau described spontaneous, recurrent superficial migratory thrombophlebitis associated with occult cancers, and this was later correlated with disseminated microangiopathy (platelet-rich clots in small blood vessels). Trousseau syndrome often occurs with mucinous adenocarcinomas, which secrete abnormally glycosylated mucins and mucin fragments into the bloodstream. Since carcinoma mucins can have binding sites for selectins, we hypothesized that selectin-mucin interactions might trigger this syndrome. When highly purified, tissue-factor free carcinoma mucin preparations were intravenously injected into mice, platelet-rich microthrombi were rapidly generated. This pathology was markedly diminished in P- or L-selectin–deficient mice. Heparin (an antithrombin-potentiating agent that can also block P- and L-selectin recognition of ligands) ameliorated this platelet aggregation, but had no additional effect in P- or L-selectin–deficient mice. Inhibition of endogenous thrombin by recombinant hirudin also did not block platelet aggregation. Mucins generated platelet aggregation in vitro in hirudinized whole blood, but not in platelet-rich leukocyte-free plasma nor in whole blood from L-selectin–deficient mice. Thus, Trousseau syndrome is likely triggered by interactions of circulating carcinoma mucins with leukocyte L-selectin and platelet P-selectin without requiring accompanying thrombin generation. These data may also explain why heparin ameliorates Trousseau syndrome, while vitamin K antagonists that merely depress thrombin production do not.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci200318882

Cites

87 of 88 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 4

  1. Trousseau, A. 1868. Lectures on clinical medicine, delivered at the Hotel-Dieu, Paris. P.V. Bazire, editor and translator. The New Sydenham Society Publications. London, United Kingdom. 55 :281-332.
  2. Rhodes, J.M. 1999. Usefulness of novel tumour markers. Ann. Oncol. 4 (Suppl. 10):118-121. · doi:10.1023/a:1008369626649
  3. Beeley, J.G. 1985. Glycoprotein and proteoglycan techniques . Elsevier. New York, New York, USA. 73-78.
  4. Corriveau, D., and Fritsma, J. 1988. Hemostasis and thrombosis in the clinical laboratory . 1988. J.P. Lippincott Co. Philadelphia, Pennsylvania, USA. 443 pp.

Cited by

See all 318

Metadata

Authors
Wahrenbrock, M., Borsig, L., Le, D., Varki, N., & Varki, A.
Affiliations
University of California San Diego (US)
Corresponding author
Varki, Ajit
Venue
Journal of Clinical Investigation
Published
2003-09-15
Volume
112
Issue
6
Pages
853-862
ISSN
0021-9738 (ISSN-L)
OpenAlex
W4249976229
Cited by
317
References
87
Citations by year
2026: 11 · 2025: 14 · 2024: 14 · 2023: 8 · 2022: 10 · 2021: 26 · 2020: 18 · 2019: 20 · 2018: 14 · 2017: 13 · 2016: 20 · 2015: 21 · 2014: 13 · 2013: 10 · 2012: 14
FWCI
4.15
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • U.S. Public Health Service
  • National Cancer Institute (R01 CA 38701, R01CA038701)
Topics
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
  • Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
  • Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
Keywords
Trousseau syndrome, mucinous adenocarcinoma, P-selectin, L-selectin, platelet aggregation, microvascular thrombosis, heparin, hirudin, vitamin K antagonists, thrombophlebitis
MeSH terms
Animals, Antifibrinolytic Agents, Blood Platelets, Adenocarcinoma, Mucinous, Fibrinolytic Agents, Heparin, Humans, Lung, Mice, Inbred C57BL, Mucins, Neoplasm Transplantation, Paraneoplastic Syndromes, Syndrome, Thrombin, Thrombophlebitis, Thrombosis, Transplantation, Heterologous, Tumor Cells, Cultured, Vitamin K, Platelet Activation, Comorbidity, P-Selectin, L-Selectin, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.